HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fewer hospitalizations for chronic obstructive pulmonary disease in communities with smoke-free public policies.

AbstractOBJECTIVES:
We determined the impact of smoke-free municipal public policies on hospitalizations for chronic obstructive pulmonary disease (COPD).
METHODS:
We conducted a secondary analysis of hospital discharges with a primary diagnosis of COPD in Kentucky between July 1, 2003, and June 30, 2011 using Poisson regression. We compared the hospitalization rates of regions with and without smoke-free laws, adjusting for personal and population covariates, seasonality, secular trends over time, and geographic region.
RESULTS:
Controlling for covariates such as sex, age, length of stay, race/ethnicity, education, income, and urban-rural status, among others, we found that those living in a community with a comprehensive smoke-free law or regulation were 22% less likely to experience hospitalizations for COPD than those living in a community with a moderate-weak law or no law. Those living in a community with an established law were 21% less likely to be hospitalized for COPD than those with newer laws or no laws.
CONCLUSIONS:
Strong smoke-free public policies may provide protection against COPD hospitalizations, particularly after 12 months, with the potential to save lives and decrease health care costs.
AuthorsEllen J Hahn, Mary Kay Rayens, Sarah Adkins, Nick Simpson, Susan Frazier, David M Mannino
JournalAmerican journal of public health (Am J Public Health) Vol. 104 Issue 6 Pg. 1059-65 (Jun 2014) ISSN: 1541-0048 [Electronic] United States
PMID24825207 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Aged
  • Aged, 80 and over
  • Behavioral Risk Factor Surveillance System
  • Female
  • Hospitalization (statistics & numerical data)
  • Humans
  • Kentucky (epidemiology)
  • Length of Stay (statistics & numerical data)
  • Male
  • Middle Aged
  • Public Policy
  • Pulmonary Disease, Chronic Obstructive (epidemiology, therapy)
  • Smoke-Free Policy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: